---
title: "Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial"
date: 2022-06-17
enddate:
---

Published in: *Nature Medicine*

DOI: [10.1038/s41591-022-01866-4](https://doi.org/10.1038/s41591-022-01866-4)

<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/800px-Open_Access_logo_PLoS_transparent.svg.png" alt="drawing" width="50" align="left"/> &nbsp;&nbsp;&nbsp;This publication is available in **Open Access**! (Hybrid OA)

&nbsp;&nbsp;&nbsp;<a href="https://www.nature.com/articles/s41591-022-01866-4.pdf">Access it freely here</a>

